AI continues to reshape healthcare, and Heidi Health is emerging as one of the sector’s most promising disruptors. The Australia-based startup has secured $65 million in Series B funding led by Steve Cohen’s Point72 Private Investments, as it scales its AI-powered medical assistant designed to ease the administrative load on doctors and clinicians.
Founded in 2021 by Dr. Tom Kelly, a trauma surgeon, and Waleed Mussa, Heidi Health was born from a simple but powerful observation — healthcare professionals spend far too much time on paperwork instead of patients. “We wanted to build an AI care partner that would stand alongside clinicians and take care of the admin,” said Dr. Kelly. “Doctors should feel empowered to deliver the care we dedicated our lives to.”
In just 18 months, Heidi Health’s technology has already freed up more than 18 million clinical hours across 70 million patient visits in over 100 countries, helping doctors focus on patient care instead of documentation. Its flagship product is an AI medical scribe capable of transcribing, summarizing, and managing patient interactions automatically.
The company uses a model-agnostic approach, developing its own AI systems while also integrating advanced models such as Google’s Gemini to enhance performance and reliability. Alongside the funding, Heidi Health also unveiled a new AI agent that can call patients on behalf of doctors, taking automation in healthcare one step further.
Joining the company are notable healthcare and tech veterans — Dr. Simon Kos, former Chief Medical Officer at Microsoft, and Paul Williamson, Head of Revenue at Plaid.
The round, which brings Heidi Health’s total funding to $96.6 million, also saw participation from Goodwater Capital, Headline, Blackbird VC, LG Technology Ventures, and Alumni Ventures.
According to Dr. Kelly, Point72’s decision to lead the round came down to Heidi’s real-world traction and strong user adoption. “They’d seen all the scribes before — but never product engagement like Heidi’s,” he said. “They also valued our obsession with end-user experience.”
The fresh capital will go toward advancing product development and expanding accessibility to clinicians globally. Kelly envisions Heidi as a tool that can empower healthcare providers everywhere — from hospitals in developed cities to field medics in war zones or disaster-stricken regions.
He believes AI won’t replace doctors, but rather amplify their capacity. “It’s about doubling the world’s healthcare capacity,” he said. “That’s the true promise of AI — enabling more people to receive care, wherever they are.”
Other notable players in the AI scribe space include DeepScribe, Ambience Healthcare, and Abridge, signaling a growing trend in medical automation. But with more than 2 million clinicians using Heidi Health weekly, the company is positioning itself as a front-runner in redefining how AI partners with human care.